Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
- Country:
- France
French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.
As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
GLOBAL MARKETS-Asian shares fall on U.S. rate scare, yen plumbs 34-yr low
EMERGING MARKETS-Stocks, FX slide after U.S. inflation print triggers global selloff
GLOBAL MARKETS-Europe turns to ECB after U.S. inflation selloff
Russia and U.S. are in contact over non-deployment of nuclear weapons in space - TASS
GLOBAL MARKETS-Europe turns to ECB after U.S. inflation scare